MELANIE RAMOS: Open Payments
NPI 1043891047 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 40 payments from 15 companies in 2025. Trend: 2023 $856 · 2024 $982 · 2025 $1,145
Food & beverage: $1,122Education: $23
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 5 | $163 |
| SOBI, INC | 4 | $119 |
| Lilly USA, LLC | 4 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $109 |
| GlaxoSmithKline, LLC. | 4 | $108 |
| ABBVIE INC. | 3 | $92 |
| Celgene Corporation | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Incyte Corporation | 2 | $50 |
Products named: Vonjo, JAYPIRCA, SCEMBLIX, OJJAARA, CALQUENCE, EPKINLY, REBLOZYL, ICLUSIG.
Industry payments across TX — which companies pay providers there.
